Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lateral Lymph Node Features and Tumor Regression Grade After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Impact on Oncological Outcomes.

NCT05592873 is registered in ClinicalTrials.gov with Niguarda Hospital as lead sponsor.

NCT NCT05592873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05592873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lateral Lymph Node Features and Tumor Regression Grade After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Impact on Oncological Outcomes.
Lead sponsor
Niguarda Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
September 30, 2022
Enrollment
317 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma